From: Primary neuroendocrine tumor of the pineal gland: a case report
Source | Intracranial Location | Age (y.) | Sex | Treatment | Overall survival | Cause of death |
---|---|---|---|---|---|---|
Hakar et al. | Pineal parenchyma | 35 | Female | Subtotal resection Cisplatin, etoposide, sunitinib Craniospinal irradiation | Died 26 months following diagnosis | Cancer progression |
Liu et al. | Sella/hypothalamic | 39 | Female | Resection | Died three months following diagnosis | Cancer progression, too unwell to receive radiotherapy |
Liu et al. | Anterior cranial fossa | 40 | Female | Resection | At time of publication, patient alive, but undisclosed timeline | - |
Reed et al. | Intraventricular, third ventricle | 34 | Female | Resection Intensity modulated radiation therapy Cisplatin and etoposide | Followed for five years with no recurrence Recurrence 10 years after initial diagnosis, died 2 months after | Complications of hydrocephalus secondary to recurrence |
Ibrahim et al. | Skull base, level of jugular foramen | 29 | Female | Monthly somatostatin injections Patient declined radiotherapy | Followed for one year with stable disease | - |
Hood et al. | Left cavernous sinus | 61 | Female | Subtotal resection Fractionated external beam radiation therapy | Followed for 7.5 years with stable disease | - |
Deshaies et al. | Dural-based, compressing right frontal lobe | 79 | Female | Resection Octreotide | Died 6 weeks after diagnosis | Unknown complications |
Cao et al. | Multiple lesions, left parietal convexity, right occipital parietal convexity, left frontal convexity, left cerebral falx, right temporal lobe | 56 | Female | Resection of three lesions Whole brain and tumor bed radiotherapy Temozolomide with recombinant human endostatin | Followed for 10 months with stable disease | - |
Porter et al. | Right cerebellopontine angle of posterior fossa | 62 | Male | Subtotal resection | At time of publication, 5-year survival | - |
Our study | Pineal parenchyma | 53 | Male | Subtotal resection Temozolomide Craniospinal irradiation | Died 18 months after diagnosis | Cancer progression |